About Embold Therapeutics
Embold Therapeutics is a private company based in Redwood City, California, incorporated in 2023 in Delaware. It has reported $2,970,587 raised in two offerings on Form D since February 2026. Its chief executive is Gjalt Huisman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | Feb 9, 2026amended Jul 24, 2026 | $2,470,587of $4.9M target | 7 | $352K | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 21, 2026 | Feb 9, 2026 | $500,000fully sold | 1 | $500K | Options, Securities on exerciseRule 504 | Form D ↗ |
| Total, two offerings | $2,970,587 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Embold Therapeutics's Form D filed Jul 24, 2026.
GH